Changes to Biohit Oyj’s management

Stock exchange release Biohit Oyj

24th May 2021 at 01.30 pm local time (EEST)

Master of Social Sciences Jussi Hahtela (b. 1973) has been appointed Chief Financial Officer and as a member of the Management Team of Biohit Oyj starting June 4th 2021. He will also be responsible for HR function and IT function. Hahtela will report to deputy CEO Osmo Suovaniemi. Hahtela has previously worked in Nordea for example as chief strategist and Head of FX sales Finland.

Additional information:

Chairman of the Board Osmo Suovaniemi, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com